| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA125307
Max Phase: Preclinical
Molecular Formula: C17H27NO5S
Molecular Weight: 357.47
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCOc1ccc2c(c1)C(N(C)S(C)(=O)=O)C(O)C(C)(C)O2
Standard InChI: InChI=1S/C17H27NO5S/c1-6-7-10-22-12-8-9-14-13(11-12)15(18(4)24(5,20)21)16(19)17(2,3)23-14/h8-9,11,15-16,19H,6-7,10H2,1-5H3
Standard InChI Key: ICXASNQRNZTLLB-UHFFFAOYSA-N
Associated Targets(Human)
Voltage-gated potassium channel, IKs; KCNQ1(Kv7.1)/KCNE1(MinK) 185 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 357.47 | Molecular Weight (Monoisotopic): 357.1610 | AlogP: 2.33 | #Rotatable Bonds: 6 |
| Polar Surface Area: 76.07 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.23 | CX Basic pKa: | CX LogP: 1.60 | CX LogD: 1.60 |
| Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.79 | Np Likeness Score: 0.16 |
References
| 1. Gerlach U, Brendel J, Lang HJ, Paulus EF, Weidmann K, Brüggemann A, Busch AE, Suessbrich H, Bleich M, Greger R.. (2001) Synthesis and activity of novel and selective I(Ks)-channel blockers., 44 (23): [PMID:11689069] [10.1021/jm0109255] |
Source
Source(1):